PAB
Click for more information
0.00% 0.7¢ patrys limited

time for a reasonable discussion, page-2

  1. Kiddo
    506 Posts.
    clock Created with Sketch.
    20/11/13
    06:59
    Post #: 12592824
    Nice Sum Zaskar

    just to add to your discussion...

    Daratumumab, a "non orphan-drug", received "Breakthrough therapy destination" by the USFDA while in phase 1/2 (May 2013).

    Janssen (Sub of J&J) made a potential billion $ deal with Genmab during 2012 while Daratumumab was still in phase 1/2.


    http://www.firstwordpharma.com/node/1013741#axzz2l5ccGSt8

    http://www.onclive.com/web-exclusives/Breakthrough-Designation-Granted-to-Daratumumab-for-Double-Refractory-Multiple-Myeloma
    PAB Price at posting: 6.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GWR Scoping study and Phase 2 drilling progress Prospect Ridge magnesium play for GWR
right-arrow Created with Sketch.
NEWS Money and Investing: Talking the minefield of divorce & family law
right-arrow Created with Sketch.
HMD HeraMED delivers digital maternity care to select clinics with Telstra
right-arrow Created with Sketch.
MYR Myer lobs proposed merger at major shareholder Premier Investments
right-arrow Created with Sketch.
WAF West African Resources draws final US$100M from Sprott-backed loan for gold plant
right-arrow Created with Sketch.
CTT Cettire has launched in China – but can it turn its share price around?
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAB (ASX) to my watchlist
(20min delay)
Last
0.7¢ 		Change
0.000(0.00%) 		Mkt cap ! $14.40M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $5.4K 771.4K

Buyers (Bids)

No. Vol. Price($)
1 217541 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
0.8¢ 1986479 10
View Market Depth
Last trade - 10.06am 26/06/2024 (20 minute delay) ?
PAB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.